More Kissei Pharmaceutical Co., Ltd. news
Kissei Pharmaceutical Co., Ltd.TSE: 4547

Announcement for the Results Report by the Council of Pharmaceutical Affairs (Mdical Product Second Section) on TAVNEOS

Oct 21, 2026 at 7:30 PM EDT · Issued by Kissei Pharmaceutical Co., Ltd. via TDnet

Filed with TSE · Oct 21, 2026 at 7:30 PM EDT

On 6ix: 6ix.com/news/announcement-for-the-results-report-by-the-council-of-pharmaceutical-affairs-mdical-product-second-section-on-tavneos

KISSEI PHARMACEUTICAL CO.,LTD.

View Attachment

6ix is reading this filing.

View original source (TDnet)Kissei Pharmaceutical Co., Ltd. on 6ix

Story so far

  • Announcement for the Opnion by European Authorities on TAVNEOSJun 28, 2026

Earlier from Kissei Pharmaceutical

  • Notice Concerning Status of Acquisition of Treasury SharesOct 5
  • Notice of Completion of Payment for Treasury Shares Disposal as Restricted Stock for Employee Shareholding Association and PartialAug 10
  • Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]Jul 31
  • Notice Regarding Completion of Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate OfficersJul 23
  • Announcement for the Opnion by European Authorities on TAVNEOSJun 28
All Kissei Pharmaceutical news releases↗

Follow Kissei Pharmaceutical into a list and get an email when it puts out news.

Follow Kissei Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer